Antidepressant Makers Under Fire For Hiding Data

Law360, New York (January 17, 2008, 12:00 AM EST) -- A new study has found that the makers of a dozen popular antidepressants selectively published the results of trials they conducted to win government approval, leading to unrealistic estimates of the drugs' effectiveness by doctors and consumers.

The study, published in this week's New England Journal of Medicine, compared drug efficacy inferred from publicly reported clinical trials with drug efficacy according to reviews by the U.S. Food and Drug Administration to determine how accurately the published literature conveys data on drug efficacy to the medical community....
To view the full article, register now.